Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) have been given a consensus recommendation of “Moderate Buy” by the ten research firms that are presently covering the company, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $17.30.

A number of equities analysts recently issued reports on the company. Citigroup raised Sabra Health Care REIT from a “neutral” rating to a “buy” rating and raised their price target for the stock from $17.00 to $20.00 in a report on Friday, September 13th. Scotiabank upped their price target on shares of Sabra Health Care REIT from $15.00 to $17.00 and gave the stock a “sector perform” rating in a research report on Monday, August 26th. Finally, Truist Financial upped their price target on shares of Sabra Health Care REIT from $16.00 to $18.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th.

Sabra Health Care REIT Trading Up 0.4 %

Shares of NASDAQ SBRA opened at $18.44 on Monday. The firm has a market cap of $4.32 billion, a PE ratio of 92.20, a price-to-earnings-growth ratio of 2.72 and a beta of 1.26. The company has a quick ratio of 4.27, a current ratio of 4.27 and a debt-to-equity ratio of 0.89. Sabra Health Care REIT has a twelve month low of $12.83 and a twelve month high of $19.32. The business has a fifty day simple moving average of $17.14 and a two-hundred day simple moving average of $15.46.

Sabra Health Care REIT (NASDAQ:SBRA) last released its quarterly earnings results on Wednesday, August 7th. The real estate investment trust reported $0.10 earnings per share for the quarter, missing analysts’ consensus estimates of $0.34 by ($0.24). The business had revenue of $176.14 million during the quarter, compared to analyst estimates of $166.54 million. Sabra Health Care REIT had a return on equity of 1.87% and a net margin of 7.83%. The business’s revenue for the quarter was up 9.3% compared to the same quarter last year. During the same period in the previous year, the company posted $0.34 EPS. Analysts expect that Sabra Health Care REIT will post 1.38 earnings per share for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Monday, August 19th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 6.51%. The ex-dividend date of this dividend was Monday, August 19th. Sabra Health Care REIT’s payout ratio is 600.00%.

Institutional Investors Weigh In On Sabra Health Care REIT

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SBRA. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Sabra Health Care REIT during the 2nd quarter valued at $122,000. Cetera Investment Advisers increased its position in Sabra Health Care REIT by 1.8% during the second quarter. Cetera Investment Advisers now owns 414,052 shares of the real estate investment trust’s stock worth $6,376,000 after acquiring an additional 7,377 shares during the period. Truist Financial Corp increased its position in Sabra Health Care REIT by 85.2% during the second quarter. Truist Financial Corp now owns 183,180 shares of the real estate investment trust’s stock worth $2,821,000 after acquiring an additional 84,251 shares during the period. Algert Global LLC bought a new position in Sabra Health Care REIT during the second quarter worth $359,000. Finally, Lighthouse Investment Partners LLC bought a new stake in Sabra Health Care REIT in the 2nd quarter valued at $462,000. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Health Care REIT Company Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.